- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01611922
Optimization of Assessment and Grading for Lid Wiper Epitheliopathy (BURNABY)
June 4, 2012 updated by: Alcon Research
The purpose of this study is to assess eyelid margin staining, termed "lid wiper epitheliopathy" (LWE), in three populations.
The hypothesis is LWE will be more prevalent in symptomatic contact lens wearers than non-symptomatic contact lens wearers and least prevalent in asymptomatic non-contact lens wearers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
57
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Waterloo, Canada, N2L 3G1
- Centre for Contact Lens Research, University of Waterloo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Participants will be identified and screened by the University of Waterloo in Ontario, Canada.
Description
Inclusion Criteria:
- Has full legal capacity to volunteer;
- Has read and signed an information consent letter;
- Is willing and able to follow instructions and maintain the appointment schedule;
- Has had an ocular examination in the last two years;
- Has clear corneas and no active ocular disease;
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Has any ocular disease;
- Has a systemic condition that may affect a study outcome variable;
- Is using any systemic or topical medications that may affect ocular health;
- Has known sensitivity to the diagnostic pharmaceuticals to be used in the study;
- Has undergone corneal refractive surgery;
- Currently wears contact lenses on an extended wear basis (overnight);
- Has any clinically significant lid or conjunctival abnormalities, neovascularization, corneal scars or corneal opacities;
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Symptomatic Lens Wearers
Contact lens wearers reporting a habitual wear time of less than eight hours and a noticeable reduction in comfort over a wearing day
|
Topically instilled for the purpose of assessing lid margin staining
Other Names:
Silicone hydrogel contact lenses per subject's habitual brand and power, worn for a minimum of 8 hours on the day of assessment, after which lenses will be removed and dye will be instilled.
|
Non-Symptomatic Contact Lens Wearers
Contact lens wearers reporting a comfortable wear time of more than 10 hours and minimal reduction in comfort over a wearing day
|
Topically instilled for the purpose of assessing lid margin staining
Other Names:
Silicone hydrogel contact lenses per subject's habitual brand and power, worn for a minimum of 8 hours on the day of assessment, after which lenses will be removed and dye will be instilled.
|
Asymptomatic Non-Contact Lens Wearers
Non-contact lens wearers reporting a minimal reduction in ocular comfort over the course of a day
|
Topically instilled for the purpose of assessing lid margin staining
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
LWE-associated staining score
Time Frame: 3 minutes after dye instillation
|
Lens wearers must wear lenses for a minimum of 8 hours on the day of assessment, after which lenses will be removed and dye will be instilled.
LWE-associated staining will be assessed by the investigator and reported as a composite score based on Korb's method.
|
3 minutes after dye instillation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lyndon Jones, FCOptom, PhD, Centre for Contact Lens Research, School of Optometry, University of Waterloo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2012
Primary Completion (Actual)
May 1, 2012
Study Completion (Actual)
May 1, 2012
Study Registration Dates
First Submitted
May 31, 2012
First Submitted That Met QC Criteria
June 4, 2012
First Posted (Estimate)
June 5, 2012
Study Record Updates
Last Update Posted (Estimate)
June 5, 2012
Last Update Submitted That Met QC Criteria
June 4, 2012
Last Verified
June 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P/365/11/L
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye
-
Gordon Schanzlin New VisionCompletedDry Eye | Dry Eye Disease | Evaporative Dry Eye | Kerato Conjunctivitis Sicca | Evaporative Dry Eye Disease | Dry Eye, EvaporativeUnited States
-
Kao (Taiwan) CorporationChang Gung Memorial HospitalCompletedEye Fatigue | Dry Eye SymptomTaiwan
-
Alcon ResearchCompletedVisual Performance | Dry Eye Symptoms
-
Alcon ResearchCompletedModerate to Severe Dry Eye
-
Singapore National Eye CentreCompleted
-
Bausch & Lomb IncorporatedCompletedDry Eye Disease (DED)United States
-
AllerganCompletedDry Eye Syndrome | Dry Eye DiseaseUnited States
-
Senju Pharmaceutical Co., Ltd.CompletedDry Eye Syndrome | Dry Eye DiseaseUnited States
-
Centre for Contact Lens ResearchCoopervision, Inc.CompletedContact Lens Related Dry EyeCanada
-
Singapore National Eye CentreCompleted
Clinical Trials on Ophthalmic dye
-
Vanderbilt-Ingram Cancer CenterTerminatedThyroid Carcinoma | Radioactive Iodine LevelUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingOvarian Cancer | Adnexal MassUnited States
-
Federal University of São PauloCasa de Saúde São José; Rafael R. Caiado; Acácio Alves Souza Lima-Filho; Eduardo... and other collaboratorsCompletedDiabetic Retinopathy | Epiretinal Membrane | Macular HoleBrazil
-
University Hospitals of Derby and Burton NHS Foundation...CompletedBreast Cancer | Sentinel Lymph Node | Tattoo; Pigmentation | Axilla; BreastUnited Kingdom
-
Henry Ford Health SystemWithdrawn
-
Fujian Medical University Union HospitalRecruitingBreast Cancer | Neoadjuvant Therapy | Sentinel Lymph Node BiopsyChina
-
University Health Network, TorontoSunnybrook Health Sciences CentreRecruitingSurgery Site FistulaCanada
-
Lahey ClinicCompletedEndometrial Cancer | Sentinel Lymph Node DetectionUnited States
-
Taipei Medical University WanFang HospitalTerminated
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedPort Wine StainsUnited States